SCHEMBL3081376

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3076153	0.92	AR (0.47)	ARPTGDR2NSD2BRD4GAA
	SCHEMBL3271903	0.92	AR (0.47)	ARPTGDR2NSD2GAAGFER
	SCHEMBL3070012	0.92	AR (0.50)	ARPTGDR2NSD2GAAGFER
	SCHEMBL3077429	0.92	AR (0.50)	ARPTGDR2NSD2GAAGFER
	SCHEMBL3087297	0.90	AR (0.62)	ARNSD2CYP11B2
	SCHEMBL3081423	0.90	AR (0.48)	ARPTGDR2NSD2GAAGFER
	SCHEMBL3063842	0.90	AR (0.48)	ARNSD2GAAGFER
	SCHEMBL3074078	0.90	AR (0.48)	ARNSD2BRD4GAAGFER
	SCHEMBL3076734	0.89	AR (0.50)	ARPTGDR2NSD2GAAGFER
	SCHEMBL3081229	0.89	AR (0.50)	ARNSD2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.